GI Cancer Trials

Formerly AGITG & GI Cancer Institute.

Gastro-intestinal (GI) cancer is the most common form of cancer in Australia. It affects more than 37,780 Australians each year and claims 50 lives every day. GI cancer includes cancers of the digestive system – oesophagus, stomach, liver, gallbladder and biliary tract, pancreas, large and small bowel, rectum and anus. The chance of surviving five years after diagnosis is just 48.4%.

We’re working to change that.

Clinical trials are how progress happens. They test whether new treatments work better than the current standard of care, and they’re essential to ensuring new therapies are safe, effective, and ready to be used more widely.